Eligibility Criteria
- Pathologically (histologically) proven diagnosis of prostate adenocarcinoma. Prostatectomy must have been performed within 10 years prior to Step 1 registration and any type of radical prostatectomy is permitted, including retropubic, perineal, laparoscopic or robotically assisted.
- Karnofsky performance status of 70-100 within 90 days prior to Step 1 registration
- Prior androgen deprivation therapy (LHRH agonist and/or non-steroidal anti-androgen) is allowed if discontinued at least 90 days prior to Step 1 registration and given for ≤ 90 days duration.
Please contact Legacy Oncology Research for additional study inclusion/exclusion information.